European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry

JACC: Cardiovascular Interventions

Volumn 8, Issue 5, 2015, Pages 657-669

  Schymik, Gerhard ^a   Lefèvre, Thierry ^b   Bartorelli, Antonio L ^c   Rubino, Paolo ^d   Treede, Hendrik ^e   Walther, Thomas ^f   Baumgartner, Helmut ^g   Windecker, Stephan ^h   Wendler, Olaf ⁱ   Urban, Philip ^j   Mandinov, Lazar ^k   Thomas, Martyn ^l   Vahanian, Alec ^m  

^a Municipal Hospital Karlsruhe   (Germany)

^b INSTITUT HOSPITALIER JACQUES CARTIER   (France)

^c UNIVERSITY OF MILAN   (Italy)

^d Casa di Cura Montevergine   (Italy)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f KERCKHOFF HEART CENTER   (Germany)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ KING S COLLEGE HOSPITAL   (United Kingdom)

^j LA TOUR HOSPITAL   (Switzerland)

^k EDWARDS LIFESCIENCES   (United States)

^l ST THOMAS HOSPITAL   (United Kingdom)

^m BICHAT HOSPITAL   (France)

more..

Author keywords

aortic valve stenosis; minimally invasive; transapical; transcatheter; transfemoral

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; AORTA DISSECTION; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTIC VALVE REPAIR; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY OCCLUSION; DIABETES MELLITUS; EUROSCORE; FEMALE; FOLLOW UP; HEART ARREST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TAMPONADE; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PARAVALVULAR LEAK; PERICARDIAL EFFUSION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; QUALITY OF LIFE; REGISTER; SURGICAL RISK; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; VERY ELDERLY; ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; CLINICAL TRIAL; COMORBIDITY; DEVICES; EUROPE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COMORBIDITY; EUROPE; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929170328     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.10.026     Document Type: Article

References (25)

1. J.G. Webb, and D.A. Wood Current status of transcatheter aortic valve replacement J Am Coll Cardiol 60 2012 483 492
2. P. Genereux, S. Head, and D. Wood Transcatheter-aortic valve implantation 10-year anniversary: review of current evidence and clinical implications Eur Heart J 33 2012 2388 2398
3. M. Thomas, G. Schymik, and T. Walther Thirty-day results of the SOURCE Registry. A European registry of transcatheter-aortic valve implantation using the Edwards SAPIEN valve Circulation 122 2010 62 69
4. M. Thomas, G. Schymik, and T. Walther One-year outcomes of cohort 1 in the Edwards SOURCE Registry: the European registry of transcatheter-aortic valve implantation using the Edwards SAPIEN valve Circulation 124 2011 425 433
5. M.B. Leon, N. Piazza, and E. Nikolsky Standardized endpoint definitions for transcatheter-aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium Eur Heart J 32 2011 205 217
6. A. Vahanian, O. Alfieri, and F. Andreotti Guidelines on the management of valvular heart disease (version 2012) Eur Heart J 33 2012 2451 2496
7. I. Ben-Dor, M.A. Gaglia Jr., and I.M. Barbash Comparison between STS Score and logistic EuroSCORE for predicting mortality in patients referred for transcatheter-aortic valve implantation Cardiovasc Revasc Med 12 2011 345 349
8. F. D'Ascenzo, F. Ballocca, and C. Moretti Inaccuracy of available surgical-risk scores to predict outcomes after TAVR J Cardiovasc Med (Hagerstown) 14 2013 894 898
9. M.J. Mack Risk scores for predicting outcomes in valvular heart disease: how useful? Curr Cardiol Rep 13 2011 107 112
10. N.M. Van Mieghem, and P.W. Serruys The art of risk stratification in TAVI Eur Heart J 34 2013 1859 1861
11. M. Mack Frailty and aortic valve disease J Thorac Cardiovasc Surg 145 3 Suppl 2013 S7 S10
12. B. Daneault, E. Koss, and R.T. Hahn Efficacy and safety of postdilatation to reduce paravalvular regurgitation during balloon-expandable transcatheter-aortic valve replacement Circ Cardiovasc Interv 6 2013 85 91
13. L. Nombela-Franco, H. Barbosa Ribeiro, and R. Allende Role of balloon-postdilation following TAVI Minerva Cardioangiol 61 2013 499 512
14. G. Lasa, K. Gaviria, and J.C. Sanmartin Postdilatation for treatment of perivalvular aortic regurgitation after TAVI Catheter Cardiovasc Interv 83 2014 E112 E118
15. L. Nombela-Franco, J. Rodés-Cabau, and R. DeLarochellière Predictive factors, efficacy, and safety of balloon post-dilation after TAVI with a balloon-expandable valve J Am Coll Cardiol Intv 5 2012 499 512
16. M. Barbanti, T.H. Yang, and J. Rodès Cabau Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement Circulation 128 2013 244 253
17. H. Eggebrecht, A. Schmermund, and P. Kahlert Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): a weighted meta-analysis of 9,251 patients from 46 studies EuroIntervention 8 2013 1072 1080
18. M. Gilard, H. Eltchaninoff, B. Iung FRANCE 2 Investigators Registry of transcatheter aortic-valve implantation in high-risk patients N Engl J Med 366 2012 1705 1715
19. N.E. Moat, P. Ludman, and M.A. de Belder Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The U.K. TAVI Registry J Am Coll Cardiol 58 2011 2130 2138
20. C.W. Hamm, H. Möllmann, and D. Holzhey The German Aortic Valve Registry (GARY): in-hospital outcome Eur Heart J 35 2014 1588 1598
21. A. Linke, P. Wenaweser, and U. Gerckens Treatment of aortic stenosis with a self-expanding transcatheter valve: the international multi-centre ADVANCE Study Eur Heart J 35 2014 2672 2684
22. P. Généreux, J.G. Webb, L.G. Svensson PARTNER Trial Investigators Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER trial J Am Coll Cardiol 60 2012 1043 1052
23. B. Borz, E. Durand, and M. Godin Incidence, predictors and impact of bleeding after TAVI using the balloon-expandable Edwards prosthesis Heart 99 2013 860 865
24. J. Ye, A. Cheung, and S.V. Lichtenstein Transapical transcatheter aortic valve implantation: follow-up to 3-years J Thorac Cardiovasc Surg 139 2010 1107 1113 13.e1
25. P. Généreux, S.J. Head, and R. Hahn Paravalvular leak after TAVR: the new Achilles' heel? A comprehensive review of the literature J Am Coll Cardiol 61 2013 1125 1136